Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Cloning and Mutagenesis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
The global cloning and mutagenesis market, encompassing vital sectors of biotechnology and pharmaceuticals, has entered a period of accelerated growth and innovation. This market, as a cornerstone of modern genetic research and applications, is pivotal in fueling advances across various fields ranging from personalized medicine to agricultural biotechnology.
The latest comprehensive analysis sheds light on this burgeoning sector, highlighting the market's remarkable expansion from $2.53 billion in 2023 to a projection of $6.07 billion in 2028, expanding at a compound annual growth rate (CAGR) of 18.8%. This growth trend underscores the escalating demand for cloning and mutagenesis technologies spurred by their wide-ranging applications in gene therapy, genomic research, and the development of personalized medicinal solutions.
The Surge of Personalized Medicine as a Market Growth Driver
The advancement and increased demand in personalized medicine play a significant role in propelling the cloning and mutagenesis market forward. By leveraging precise genetic engineering techniques, personalized medicine has transitioned from conceptual to practical, offering tailor-made therapeutic regimens based on individual genetic makeup.
Trends and Innovations Shaping the Future of the Market
- Emphasis on targeted gene editing in therapeutic interventions.
- Enhanced precision and specificity in molecular tools for genomic manipulation.
- Expansion of cloning and mutagenesis applications in agricultural biotechnology, fostering sustainable crop production.
- Adherence to ethical and regulatory considerations guiding the cloning and mutagenesis sector.
Businesses leading in the cloning and mutagenesis sector are setting benchmarks through strategic use of advanced technologies. iNtRON Biotechnology's 2nd generation Robot Bacteriophage technology and Bio-Rad Laboratories Inc.'s ID-Check Speciation Solution are prime examples of innovations driving the market.
Strategic Acquisitions Integrating Market Leaders
Charles River Laboratories International Inc.'s acquisition of Cognate BioServices points to a strategic consolidation to enhance capabilities and services offered in the biotechnology sector. Such acquisitions are instrumental in expanding comprehensive service offerings across the value chain of cloning and mutagenesis.
The market report offers an extensive coverage of the industry's competitive landscape, encompassing industry behemoths like Thermo Fisher Scientific, GenScript, Merck KGaA, and many more. North America stands as the largest market segment, while Asia-Pacific regions indicate the fastest growth trajectory.
In-depth analysis of the cloning and mutagenesis market covers various facets, including:
- Revenue streams from assay kits, linked biotin-peg, and Bira proteins.
- Sales of advanced techniques crucial for DNA isolation, cloning vectors, and DNA ligase.
- Market values based on 'factory gate' values tied to actual creators of goods in the sector.
A selection of companies mentioned in this report includes
- Thermo Fisher Scientific
- Takara Bio Inc.
- Agilent Technologies Inc.
- Jena Bioscience GmbH
- Transgen Biotech Co
- New England Biolabs
- Merck KGaA
- Promega Corporation
- Bio-Rad Laboratories Inc.
- Danaher
- Genomax Technologies Pte Ltd
- GENEWIZ Inc.
- abm Inc.
- GenScript
- EZBioscience
- Codex DNA Inc.
- Aragen Life Sciences
- Bio-Techne
- Charles River Laboratories
- Integrated DNA Technologies
- MedGenome
- Sino Biological Inc.
- BioChain Institute Inc.
- OriGene Technologies Inc.
- Creative Biogene
- Bioneer Corporation
- Synbio Technologies LLC
- Lucigen Corporation
- Biomatik Corporation
- Quanta BioDesign Ltd.
- Inscripta Inc.
For more information about this report visit https://www.researchandmarkets.com/r/4efc94
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
